心肌原的循环在高伤性心肌病症中的转化
Raffaella Lombardi1, Sandro Betocchi, Maria Angela Losi
1Department of Clinical Medicine, Cardiovascular and Immunological Sciences, Federico II University School of Medicine, Naples, Italy.
Circulation
|September 4, 2003
概括
在高性心肌病 (HCM) 中,原蛋白的循环增加. 增强的I型原蛋白合成和抑制的矩阵金属蛋白酶 (MMPs) 有助于HCM患者的舒张功能障碍.
科学领域:
- 心血管研究研究心血管研究
- 细胞外基质的生物化学
- 心脏病理生理学 心脏病理生理学
背景情况:
- 心肌间歇性纤维化是心肌缩性心肌病 (HCM) 的一个标志.
- 了解原体重塑对于理解HCM进展至关重要.
研究的目的:
- 为了研究高性心肌病 (HCM) 患者的原循环标记物.
- 评估 HCM 中的原循环和左心室 (LV) 扩张功能之间的关系.
主要方法:
- 放射性免疫分析和ELISA用于测量原合成 (PIIINP,PICP,PINP),降解 (ICTP),矩阵金属蛋白酶 (MMP:MMP-1,MMP-2,MMP-9) 和金属蛋白酶-1 (TIMP-1) 的组织抑制剂.
- 心声学评估了左心室 (LV) 的透析功能,估计了使用传导 (A) 和肺静脉 (AR) 波长 (A-Ar) 的被动透析功能.
- 具有限制性或伪正常的LV填充模式的患者被确定为具有被动性扩张功能障碍.
主要成果:
- 与对照组相比,HCM患者的PIIINP,ICTP,MMP-2,MMP-9和总TIMP-1水平显著更高.
- PIIINP水平与LV终端-透气直径相反相关.
- 被动扩张功能 (A-Ar) 与原I积累标记物 (PICP,PINP,ICTP) 相反,与MMP-1和MMP-2水平直接相关.
结论:
- 在患有缩性心肌病 (HCM) 的患者中,原蛋白的循环量显著增加.
- 抑制MMP-1和MMP-2,加上流行的 I 原合成与降解相比,导致HCM中被动的透缩功能障碍.
相关概念视频
Myocarditis I: Introduction
645
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy I: Introduction and Classification
826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952


